Back
Dentsply Sirona 10K Form
Sell
37
XRAY
Dentsply Sirona
Last Price:
37.48
Seasonality Move:
4.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-11-05 | 10Q | XRAY/Dentsply Sirona Quarterly |
2020-08-06 | 10Q | XRAY/Dentsply Sirona Quarterly |
2020-05-11 | 10Q | XRAY/Dentsply Sirona Quarterly |
2020-03-02 | 10K | XRAY/Dentsply Sirona Annual |
2019-11-07 | 10Q | XRAY/Dentsply Sirona Quarterly |
2019-08-02 | 10Q | XRAY/Dentsply Sirona Quarterly |
Receive XRAY News And Ratings
See the #1 stock for the next 7 days that we like better than XRAY
XRAY Financial Statistics
Sales & Book Value
Annual Sales: | $3.92B |
---|---|
Cash Flow: | $71M |
Price / Cash Flow: | 40.59 |
Annual Sales: | $17.51 |
Price / Book: | 2.14 |
Profitability
EPS (TTM): | -4.77000 |
---|---|
Net Income (TTM): | $-1.03B |
Gross Margin: | $2.13B |
Return on Equity: | -26.14% |
Return on Assets: | -13% |
Dentsply Sirona Earnings Forecast
Key Dentsply Sirona Financial Ratios
- The Gross Profit Margin over the past 37 years for XRAY is 54.23%.
- The Selling, General & Administrative Expenses for XRAY have been equal to 40.52% of Gross Profit Margin.
- The Research & Development expenses have been 4.44% of Revenue.
- The Interest Expense is -6.32% of Operating Income.
- The Net Earning history of XRAY is -24.22% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 23 years.
Dentsply Sirona Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Medical Instruments & Supplies |
Sector: | Healthcare |
Current Symbol: | XRAY |
CUSIP: | 24906P |
Website: | dentsplysirona.com |
Debt
Debt-to-Equity Ratio: | 0.57 |
---|---|
Current Ratio: | 1.51 |
Quick Ratio: | 0.76 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 16.37 |
XRAY Technical Analysis vs Fundamental Analysis
Sell
37
Dentsply Sirona (XRAY)
is a Sell
Is Dentsply Sirona a Buy or a Sell?
-
Dentsply Sirona stock is rated a Sell
The current Dentsply Sirona [XRAY] share price is $37.48. The Score for XRAY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.